From a physiopathological point of view, the effectiveness and safety of EVLCD could be explained as patients assumed too few carbohydrates to develop marked hyperglycemia and too few insulin units to develop marked hypoglycemia, achieving a satisfactory overall control of the disease through the limitations of the variables involved in the pathophysiology of the disease itself. This evidence concerns the gene INS and Hyperglycemia.